ABOS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Acumen Pharmaceuticals Inc (ABOS).


$103.34M Market Cap.

As of 03/27/2025 5:00 PM ET (MRY) • Disclaimer

ABOS Market Cap. (MRY)


ABOS Shares Outstanding (MRY)


ABOS Assets (MRY)


Total Assets

$238.99M

Total Liabilities

$57.18M

Total Investments

$195.90M

ABOS Income (MRY)


Revenue

$0

Net Income

-$102.33M

Operating Expense

$114.02M

ABOS Cash Flow (MRY)


CF Operations

-$86.22M

CF Investing

$48.03M

CF Financing

$6.93M

ABOS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

ABOS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$238,992,000 (-22.94%)

$310,125,000 (57.75%)

$196,587,000 (-14.65%)

$230,330,000 (418.42%)

Assets Current

$178,306,000 (-27.70%)

$246,615,000 (36.76%)

$180,329,000 (-9.23%)

$198,661,000 (347.14%)

Assets Non-Current

$60,686,000 (-4.45%)

$63,510,000 (290.64%)

$16,258,000 (-48.66%)

$31,669,000 (0%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$181,816,000 (-31.90%)

$266,973,000 (41.42%)

$188,775,000 (-16.17%)

$225,183,000 (1311.25%)

Property Plant & Equipment Net

$0 (0%)

$503,000 (86.30%)

$270,000 (650.00%)

$36,000 (0%)

Cash & Equivalents

$35,859,000 (-46.57%)

$67,119,000 (-48.41%)

$130,101,000 (6.50%)

$122,162,000 (179.06%)

Accumulated Other Comprehensive Income

-$48,000 (-115.38%)

$312,000 (141.54%)

-$751,000 (-225.11%)

-$231,000 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$195,898,000 (-18.10%)

$239,189,000 (277.62%)

$63,341,000 (-38.92%)

$103,694,000 (0%)

Investments Current

$135,930,000 (-23.05%)

$176,636,000 (271.83%)

$47,504,000 (-34.09%)

$72,075,000 (0%)

Investments Non-Current

$59,968,000 (-4.13%)

$62,553,000 (294.98%)

$15,837,000 (-49.91%)

$31,619,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$5,648,000 (309.57%)

$1,379,000 (-15.91%)

$1,640,000 (50.74%)

$1,088,000 (104.90%)

Accumulated Retained Earnings (Deficit)

-$325,127,000 (-45.93%)

-$222,798,000 (-30.73%)

-$170,427,000 (-33.59%)

-$127,571,000 (-373.10%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$29,419,000 (-5.24%)

$31,047,000 (29468.57%)

$105,000 (0%)

$0 (0%)

Debt Current

$0 (0%)

$866,000 (724.76%)

$105,000 (0%)

$0 (0%)

Debt Non-Current

$29,419,000 (-2.52%)

$30,181,000 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$57,176,000 (32.50%)

$43,152,000 (452.38%)

$7,812,000 (51.78%)

$5,147,000 (-19.16%)

Liabilities Current

$27,607,000 (112.84%)

$12,971,000 (66.04%)

$7,812,000 (51.78%)

$5,147,000 (-19.16%)

Liabilities Non-Current

$29,569,000 (-2.03%)

$30,181,000 (0%)

$0 (0%)

$0 (0%)

ABOS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$20,219,000 (7.43%)

$18,820,000 (46.16%)

$12,876,000 (76.89%)

$7,279,000 (438.79%)

Research & Development Expense

$93,798,000 (121.65%)

$42,318,000 (30.77%)

$32,361,000 (162.99%)

$12,305,000 (53.87%)

Operating Expenses

$114,017,000 (86.49%)

$61,138,000 (35.15%)

$45,237,000 (130.99%)

$19,584,000 (109.50%)

Interest Expense

$4,068,000 (600.17%)

$581,000 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$102,329,000 (-95.39%)

-$52,371,000 (-22.20%)

-$42,856,000 (57.40%)

-$100,606,000 (-1273.46%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$102,329,000 (-95.39%)

-$52,371,000 (-22.20%)

-$42,856,000 (57.40%)

-$100,606,000 (-1273.46%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$102,329,000 (-95.39%)

-$52,371,000 (-22.20%)

-$42,856,000 (57.40%)

-$100,606,000 (-1273.46%)

Weighted Average Shares

$60,013,277 (23.46%)

$48,609,383 (19.72%)

$40,601,936 (102.43%)

$20,057,534 (4685.58%)

Weighted Average Shares Diluted

$60,013,277 (23.46%)

$48,609,383 (19.72%)

$40,601,936 (102.43%)

$20,057,534 (4685.58%)

Earning Before Interest & Taxes (EBIT)

-$98,261,000 (-89.73%)

-$51,790,000 (-20.85%)

-$42,856,000 (57.40%)

-$100,606,000 (-1273.46%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$114,017,000 (-86.49%)

-$61,138,000 (-35.15%)

-$45,237,000 (-130.99%)

-$19,584,000 (-109.50%)

ABOS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$48,027,000 (127.98%)

-$171,671,000 (-538.10%)

$39,185,000 (137.63%)

-$104,120,000 (0%)

Net Cash Flow from Financing

$6,928,000 (-95.43%)

$151,753,000 (3784.13%)

$3,907,000 (-98.05%)

$200,466,000 (348.72%)

Net Cash Flow from Operations

-$86,215,000 (-100.20%)

-$43,064,000 (-22.50%)

-$35,153,000 (-95.72%)

-$17,961,000 (-141.09%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$31,260,000 (50.37%)

-$62,982,000 (-893.32%)

$7,939,000 (-89.87%)

$78,385,000 (110.57%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$48,043,000 (127.99%)

-$171,653,000 (-536.27%)

$39,346,000 (137.80%)

-$104,080,000 (0%)

Capital Expenditure

-$16,000 (11.11%)

-$18,000 (88.82%)

-$161,000 (-302.50%)

-$40,000 (0%)

Issuance (Repayment) of Debt Securities

-$739,000 (-102.50%)

$29,524,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$7,897,000 (-93.54%)

$122,229,000 (3028.46%)

$3,907,000 (-97.69%)

$169,185,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$9,635,000 (56.79%)

$6,145,000 (100.75%)

$3,061,000 (232.00%)

$922,000 (498.70%)

Depreciation Amortization & Accretion

$178,000 (-3.26%)

$184,000 (8.88%)

$169,000 (4125.00%)

$4,000 (0%)

ABOS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-45.20% (-93.16%)

-23.40% (-10.38%)

-21.20% (83.83%)

-131.10% (-368.65%)

Return on Average Assets (ROAA)

-37.40% (-71.56%)

-21.80% (-5.83%)

-20.60% (70.27%)

-69.30% (-144.88%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-41.00% (-26.54%)

-32.40% (43.06%)

-56.90% (75.97%)

-236.80% (-201.63%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-1.01 (71.71%)

-3.56 (30.19%)

-5.09 (-278.17%)

-1.35

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.57 (-31.81%)

0.83 (-28.86%)

1.17 (-3.62%)

1.22

Debt to Equity Ratio (D/E)

0.31 (93.83%)

0.16 (295.12%)

0.04 (78.26%)

0.02 (106.73%)

Earnings Per Share (EPS)

-1.71 (-58.33%)

-1.08 (-1.89%)

-1.06 (78.88%)

-5.02 (71.28%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.44 (-62.19%)

-0.89 (-1.84%)

-0.87 (3.01%)

-0.9 (94.95%)

Book Value Per Share (BVPS)

3.03 (-44.83%)

5.49 (18.13%)

4.65 (-58.59%)

11.23 (125.31%)

Tangible Assets Book Value Per Share (TABVPS)

3.98 (-37.59%)

6.38 (31.76%)

4.84 (-57.83%)

11.48 (-89.17%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (50.00%)

-2 (-100.00%)

-1 (0.00%)

-1

Enterprise Value Over EBITDA (EV/EBITDA)

-1.02 (58.68%)

-2.47 (-65.50%)

-1.49 (-8.76%)

-1.37

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

6.46 (-66.03%)

19.01 (-17.64%)

23.08 (-40.19%)

38.6 (453.12%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$86,231,000 (-100.16%)

-$43,082,000 (-22.00%)

-$35,314,000 (-96.18%)

-$18,001,000 (-141.62%)

Enterprise Value (EV)

$99,905,218 (-21.50%)

$127,272,170 (100.15%)

$63,589,534 (-53.85%)

$137,777,383

Earnings Before Tax (EBT)

-$102,329,000 (-95.39%)

-$52,371,000 (-22.20%)

-$42,856,000 (57.40%)

-$100,606,000 (-1273.46%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$98,083,000 (-90.06%)

-$51,606,000 (-20.89%)

-$42,687,000 (57.57%)

-$100,602,000 (-1273.41%)

Invested Capital

$204,945,000 (-21.50%)

$261,082,000 (344.18%)

$58,779,000 (-42.94%)

$103,021,000 (1902.64%)

Working Capital

$150,699,000 (-35.50%)

$233,644,000 (35.43%)

$172,517,000 (-10.85%)

$193,514,000 (408.42%)

Tangible Asset Value

$238,992,000 (-22.94%)

$310,125,000 (57.75%)

$196,587,000 (-14.65%)

$230,330,000 (418.42%)

Market Capitalization

$103,337,218 (-53.53%)

$222,376,170 (0.62%)

$220,996,534 (-19.22%)

$273,579,383

Average Equity

$226,249,750 (1.09%)

$223,801,250 (10.79%)

$202,008,500 (163.20%)

$76,750,500 (611.48%)

Average Assets

$273,961,750 (13.94%)

$240,441,250 (15.65%)

$207,904,000 (43.26%)

$145,123,750 (460.85%)

Invested Capital Average

$239,891,750 (50.15%)

$159,764,750 (112.13%)

$75,313,750 (77.23%)

$42,494,000 (1451.81%)

Shares

60,079,778 (3.75%)

57,910,461 (41.50%)

40,925,284 (1.12%)

40,470,323